Interestingly, mutations in RET protein have been previously considered as a hallmark of medullary thyroid carcinoma, since they were reported in 40–80% of medullary thyroid cancer patients and were highly associated with poor prognosis—in terms of more metastasis, larger tumor sizes and poorer overall survival8,34–36. Here, RET is linked to neoplasm.